1. Response to heart failure treatment in patients with anthracyclines and trastuzumab induced left ventricular dysfunction. (3rd October 2022) Authors: Del Castillo, S; Fileni, L; Llamedo, C; Capdeville, S; Scarponi, C; Belziti, C; Falconi, M; Perez De Arenaza, D; Rossi, E; Pizarro, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Usefulness of ultra-sensitive troponin to predict anthracyclines and trastuzumab related cardiac dysfunction. (3rd October 2022) Authors: Del Castillo, S; Llamedo, C; Capdeville, S; Fileni, L; Scarponi, C; Belziti, C; Rossi, E; Falconi, M; Perez De Arenaza, D; Pizarro, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗